Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) CEO James Lanthier tells Proactive the Toronto-based biotech's 'Family 4 compounds' a group of patent-pending chemicals have shown positive in vitro screening characteristics.
Lanthier says this means these compounds, inspired by DMT, act just as strongly as some of the key serotonin receptors, which could help patients with depression and other mental health symptoms.